Title of Collaborative Activity: |
Best Pharmaceuticals for Children Act Working Group (BPCA) |
Description of Collaborative Activity: |
This working group supports the goals of the Best Pharmaceuticals for Children Act (BPCA). The BPCA seeks to improve the level of information—in scientific publications and on the label—about pharmaceuticals used to treat children. The BPCA requires that the NIH identify the drugs of highest priority for study in pediatric populations and publish a list of drugs/needs in pediatric therapeutics. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
Unknown |
NIH Participating Institutes/Centers/Office of the Director: |
NICHD |
HHS Agency Collaborators on this Activity: |
FDA |
